Unizima is catalyzing the geographically diversified manufacturing
of biologics.
PROVIDING END-TO-END SOLUTIONS FOR YOUR BIOMANUFACTURING NEEDS
Unizima is a biomanufacturing services and technology provider, providing the expertise and technology needed to enable sustainable production of biologics such as vaccines, monoclonal antibodies and insulin in new regions.
We serve as a trusted partner for biopharma manufacturers, governments and global health agencies to make biologics production in low- and middle-income countries (LMICs) and emerging markets a reality.
We are driven by the end goal of delivering life-changing biologics to people who would otherwise lack access to them. We are part of the Univercells Group and share its ground-breaking technology and engineering innovations.
Company Details
- Employees
- 15
- Address
- Allée Centrale, 52, Jumet,- 6040,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://unizima.com/
- Keywords
- technology provider.
- HQ
- Jumet
Unizima Questions
Unizima's website is https://unizima.com/
Unizima's LinkedIn profile is https://be.linkedin.com/company/unizima
Unizima has
15 employees.
View email and phone details for 15
employees at Unizima.
Unizima's industry is
Biotechnology Research
Unizima's top competitors are
Celyad Oncology,
Exothera,
Univercells,
Biosenic S.a.,
Cellistic,
Quantoom Biosciences,
Univercells Technologies, A Donaldson Life Sciences Business,
Novadip Biosciences S.a.,
Cellaïon,
Oncodna.
Unizima's categories are Biotechnology Research
